Market closed
Predictive Oncology Inc./$POAI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Ticker
$POAI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
24
Website
POAI Metrics
BasicAdvanced
$8.7M
-
-$2.32
1.11
-
Price and volume
Market cap
$8.7M
Beta
1.11
52-week high
$2.60
52-week low
$0.92
Average daily volume
5.5M
Financial strength
Current ratio
0.619
Quick ratio
0.412
Long term debt to equity
-769.083
Total debt to equity
-1,051.763
Management effectiveness
Return on assets (TTM)
-70.52%
Return on equity (TTM)
-269.18%
Valuation
Price to revenue (TTM)
3.282
Price to book
-32.03
Price to tangible book (TTM)
-15.76
Price to free cash flow (TTM)
-0.445
Growth
Revenue change (TTM)
-0.24%
Earnings per share change (TTM)
-33.33%
3-year revenue growth (CAGR)
4.56%
3-year earnings per share growth (CAGR)
-31.42%
POAI News
AllArticlesVideos
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
GlobeNewsWire·2 weeks ago
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
GlobeNewsWire·3 weeks ago
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Predictive Oncology Inc. stock?
Predictive Oncology Inc. (POAI) has a market cap of $8.7M as of April 16, 2025.
What is the P/E ratio for Predictive Oncology Inc. stock?
The price to earnings (P/E) ratio for Predictive Oncology Inc. (POAI) stock is 0 as of April 16, 2025.
Does Predictive Oncology Inc. stock pay dividends?
No, Predictive Oncology Inc. (POAI) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Predictive Oncology Inc. dividend payment date?
Predictive Oncology Inc. (POAI) stock does not pay dividends to its shareholders.
What is the beta indicator for Predictive Oncology Inc.?
Predictive Oncology Inc. (POAI) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.